Close this search box.

Venture Report: Australia’s Brandon Capital raises its largest fund yet

ARTICLE | Finance

Plus VC rounds for ITM Isotope, Nucleus and Vilya

By Paul Bonanos, Director of Biopharma Intelligence

June 7, 2024 12:45 AM UTC

As Brandon Capital invests the A$270 million ($180 million) it has raised thus far for its sixth fund, the firm will aim to disburse about half of the cash in Australia and New Zealand, with the rest going elsewhere around the globe.

Brandon has set a A$350 million goal for the vehicle, which is already larger than the firm’s A$250 million fifth fund. The Queensland Investment Corp. is a first-time investor; returning LPs include biotech CSL Ltd. (ASX:CSL) and Australian pension funds Hostplus and Hesta. The firm has now opened up the fund to add Australian family offices and overseas LPs…